LEADER 02456oas  2200925 a 450 
001 9910135212503321
005 20251106213014.0
011   $a1527-3458
035   $a(DE-599)ZDB2232639-X
035   $a(OCoLC)42729623
035   $a(CONSER)sn 99004751 
035   $a(CKB)110985822459688
035   $a(EXLCZ)99110985822459688
100   $a19991029b19952007  sy         a
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCNS drug reviews
210   $aBranford, CT $cNeva Press
210 3 $aMalden, MA $cBlackwell Pub
300   $aRefereed/Peer-reviewed
311 08$a1080-563X 
531 0 $aCNS drug rev.
606   $aNeuropharmacology$vPeriodicals
606   $aCentral nervous system$xDiseases$xEffect of drugs on$vPeriodicals
606   $aCentral Nervous System Agents$xpharmacology
606   $aCentral Nervous System Diseases$xdrug therapy
606   $aNeuropharmacologie$vPe?riodiques
606   $aSyste?me nerveux central$xMaladies$xEffets des me?dicaments sur$vPe?riodiques
606   $aNeuropharmacology$2fast$3(OCoLC)fst01036458
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aNeuropharmacology
615  0$aCentral nervous system$xDiseases$xEffect of drugs on
615  2$aCentral Nervous System Agents$xpharmacology.
615  2$aCentral Nervous System Diseases$xdrug therapy.
615  6$aNeuropharmacologie
615  6$aSyste?me nerveux central$xMaladies$xEffets des me?dicaments sur
615  7$aNeuropharmacology.
676   $a611
801  0$bNSD
801  1$bNSD
801  2$bOCLCQ
801  2$bNSD
801  2$bIPL
801  2$bCUS
801  2$bOCLCQ
801  2$bOCL
801  2$bOCLCQ
801  2$bHEBIS
801  2$bBUF
801  2$bAU@
801  2$bOCLCQ
801  2$bZ5A
801  2$bOCLCO
801  2$bOCLCA
801  2$bOCLCF
801  2$bU3W
801  2$bOCLCO
801  2$bUKMGB
801  2$bWYU
801  2$bAUD
801  2$bVT2
801  2$bOCLCO
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCQ
801  2$bBWN
801  2$bOCLCA
801  2$bOCLCO
801  2$bOCLCQ
801  2$bUAB
801  2$bOCLCL
801  2$bOCLCQ
906   $aJOURNAL
912   $a9910135212503321
996   $aCNS drug reviews$92004414
997   $aUNINA